Search

Your search keyword '"Chen, Shao-Liang"' showing total 11 results
Start Over Author "Chen, Shao-Liang" Journal international journal of cardiology
11 results on '"Chen, Shao-Liang"'

2. Provisional vs. two-stent technique for unprotected left main coronary artery disease after ten years follow up: A propensity matched analysis

Author

D'Ascenzo, Fabrizio, Iannaccone, Mario, Giordana, Francesca, Chieffo, Alaide, Connor, Stephen O., Napp, L. Christian, Chandran, SujaySubash, de la Torre Hernández, José María, Chen, Shao-Liang, Varbella, Ferdinando, Omedè, Pierluigi, Taha, Salma, Meliga, Emanuele, Kawamoto, Hiroyoshi, Montefusco, Antonio, Chong, Mervyn, Garot, Philippe, Sin, Lin, Gasparetto, Valeria, Abdirashid, Mohamed, Cerrato, Enrico, Biondi-Zoccai, Giuseppe, Gaita, Fiorenzo, Escaned, Javier, Hiddick Smith, David, Lefèvre, Thierry, Colombo, Antonio, Sheiban, Imad, and Moretti, Claudio

Published
2016
Full Text
View/download PDF

3. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial

Author

Chong, Eric, Poh, Kian-Keong, Lu, Qingshu, Zhang, James Jun-Jie, Tan, Ning, Hou, Xu Min, Ong, Hean-Yee, Azan, Aizai, Chen, Shao-Liang, Chen, Ji-Yan, Ali, Rosli Mohd, Fang, Wei-Yi, Lau, Titus Wai Leong, and Tan, Huay-Cheem

Published
2015
Full Text
View/download PDF

7. The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial

Author

Erika Cavallero, Leor Perl, Valeria Gasparetto, Imad Sheiban, Patrizia Presbitero, Massimo Giammaria, Enrico Cerrato, Francesca Sanguineti, Giuseppe Biondi-Zoccai, Andrea Picchi, Ugo Limbruno, Pierluigi Omedè, Song Lin, Roberto Pozzi, Claudio Moretti, Marco Rossi, Alberto Palazzuoli, Thierry Lefèvre, Fabrizio D'Ascenzo, Fiorenzo Gaita, Javier Escaned, Fabrizio Ugo, Maurizio Bertaina, Chen Shao-liang, and Roberto Garbo

Subjects
0301 basic medicine, Male, medicine.medical_specialty, China, medicine.medical_treatment, Population, Contrast-induced nephropathy, Contrast Media, 030204 cardiovascular system & hematology, law.invention, 03 medical and health sciences, 0302 clinical medicine, Percutaneous Coronary Intervention, Randomized controlled trial, Double-Blind Method, law, Internal medicine, medicine, Clinical endpoint, Humans, Myocardial infarction, Acute myocardial injury, Prospective Studies, education, Ischemic Preconditioning, Aged, Aged, 80 and over, education.field_of_study, business.industry, Diabetes, Percutaneous coronary intervention, Acute Kidney Injury, Middle Aged, medicine.disease, Remote ischemic preconditioning, Cardiology and Cardiovascular Medicine, Europe, 030104 developmental biology, Conventional PCI, Ischemic Preconditioning, Myocardial, Cardiology, Ischemic preconditioning, Female, business
Abstract

Background The potential protective effects of remote ischemic preconditioning (RIPC) on contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) remain to be defined. Methods and results A double blind, randomized, placebo controlled multicenter study was performed. Patients younger than 85years old, with a renal clearance of 30–60ml/min/1.73m 2 , who were candidates for PCI for all clinical indications except for primary PCI, were allocated 1:1 to RIPC or to standard therapy. The primary endpoint was incidence of CIN. The secondary endpoint was incidence of peri-procedural myocardial infarction (PMI). From February 2013 to April 2014, 3108 patients who were scheduled for coronary angiography were screened for the study. 442 fulfilled the inclusion criteria and 223 received PCI. These patients were randomized to sham RIPC ( n =107) or treatment group ( n =116). The only pre-specified subgroup of diabetic patients included 85 (38%) cases. RIPC significantly reduced CIN incidence in the overall population (12.1% vs. 26.1%, p =0.01, with a NNT=9) and in non-diabetic patients (9.2% vs. 25.0%, p =0.02), but showed no benefit in diabetics (16.7% vs. 28.2%, p =0.21). A trend for lower PMI was seen in the intervention arm (creatine kinase - muscle brain >5 URL; 8.4% vs. 16.4%, p =0.07; troponin T >5 URL; 27% vs. 38%, p =0.21). Conclusions Remote ischemic preconditioning significantly reduces the incidence of acute kidney injury in non-diabetic patients undergoing PCI. Larger sample size is presumably needed to assess the effect of RIPC for patients with diabetes mellitus. Clinical Trial number: NCT02195726 https://www.clinicaltrial.gov/.

Published
2017

11. Response to “The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: A potentially catastrophic complication of the percutaneous coronary interventions”

Author

Chen, Shao Liang, primary, Zhang, Junjie, additional, Yei, Fei, additional, Zhu, Zhongsheng, additional, Liu, Zhizhong, additional, Lin, Song, additional, Chu, Jun, additional, Yan, Ji, additional, Zhang, Ruiyan, additional, and Kwan, Tak W., additional

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results